Brown Lisle Cummings Inc. Purchases 150 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Brown Lisle Cummings Inc. lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 33.0% during the 4th quarter, Holdings Channel reports. The fund owned 605 shares of the company’s stock after acquiring an additional 150 shares during the quarter. Brown Lisle Cummings Inc.’s holdings in GE HealthCare Technologies were worth $47,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. LGT Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares in the last quarter. Capital Performance Advisors LLP bought a new position in shares of GE HealthCare Technologies in the third quarter valued at about $26,000. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth about $26,000. Darwin Wealth Management LLC bought a new stake in GE HealthCare Technologies during the 3rd quarter worth about $31,000. Finally, Continuum Advisory LLC increased its position in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on GEHC shares. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Trading Down 0.7 %

NASDAQ GEHC opened at $86.93 on Wednesday. GE HealthCare Technologies Inc. has a 12 month low of $72.61 and a 12 month high of $94.55. The stock has a 50-day simple moving average of $83.06 and a 200 day simple moving average of $85.13. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company has a market capitalization of $39.72 billion, a PE ratio of 23.88, a P/E/G ratio of 2.92 and a beta of 1.14.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.